Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 39 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 10751332

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  2. US 10752639

    Bridged bicyclic inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  3. US 10751416

    IL-26 inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  4. US 10752581

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    The Regents of the University of California Santa · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  5. US 10752623

    Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

    Xenon Pharmaceuticals Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  6. US 10752607

    Polymorphs of N-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  7. US 10745420

    Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  8. US 10745665

    Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof

    Precision BioSciences, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  9. US 10745405

    Glucuronide prodrugs of Janus kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  10. US 10744104

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  11. US 10738043

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  12. US 10738047

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  13. US 10736894

    Methods of treating developmental syndromes with PDE10A inhibitors

    OVID THERAPEUTICS INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  14. US 10730948

    Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  15. US 10730842

    Small molecule inhibitors of DYRK1A and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  16. US 10729681

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  17. US 10730882

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  18. US 10729768

    Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

    TG Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  19. US 10723741

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  20. US 10722487

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  21. US 10723718

    Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  22. US 10722499

    Anyhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  23. US 10723759

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  24. US 10717732

    Inhibitors of influenza virus replication, application methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted